BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18682976)

  • 21. Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders.
    Esser P; Bresgen M; Fischbach R; Heimann K; Wiedemann P
    Ger J Ophthalmol; 1995 Sep; 4(5):269-74. PubMed ID: 7496336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
    Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
    Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
    Gustavsson C; Agardh E; Bengtsson B; Agardh CD
    J Diabetes Complications; 2008; 22(5):309-16. PubMed ID: 18413212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy.
    Chernykh VV; Varvarinsky EV; Smirnov EV; Chernykh DV; Trunov AN
    Indian J Ophthalmol; 2015 Jan; 63(1):33-6. PubMed ID: 25686060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased sCD200 Levels in Vitreous of Patients With Proliferative Diabetic Retinopathy and Its Correlation With VEGF and Proinflammatory Cytokines.
    Xu Y; Cheng Q; Yang B; Yu S; Xu F; Lu L; Liang X
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6565-72. PubMed ID: 26457542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Level of Cytokines in the Vitreous Body of Severe Proliferative Diabetic Retinopathy Patients Undergoing Posterior Vitrectomy.
    Raczyńska D; Lisowska KA; Pietruczuk K; Borucka J; Ślizień M; Raczyńska K; Glasner L; Witkowski JM
    Curr Pharm Des; 2018; 24(27):3276-3281. PubMed ID: 30255745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.
    Demircan N; Safran BG; Soylu M; Ozcan AA; Sizmaz S
    Eye (Lond); 2006 Dec; 20(12):1366-9. PubMed ID: 16284605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
    Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
    Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy.
    Wu F; Phone A; Lamy R; Ma D; Laotaweerungsawat S; Chen Y; Zhao T; Ma W; Zhang F; Psaras C; Stewart JM
    Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):26. PubMed ID: 32084272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of HMGB1 with oxidative stress markers and regulators in PDR.
    Abu El-Asrar AM; Alam K; Garcia-Ramirez M; Ahmad A; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G; Simó R
    Mol Vis; 2017; 23():853-871. PubMed ID: 29259392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy.
    Nowak M; Wielkoszyński T; Marek B; Kos-Kudła B; Swietochowska E; Siemińska L; Kajdaniuk D; Głogowska-Szelag J; Nowak K
    Clin Exp Med; 2008 Sep; 8(3):159-64. PubMed ID: 18791689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
    Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
    Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
    Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
    Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
    Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy.
    Hernández C; Carrasco E; García-Arumí J; Maria Segura R; Simó R
    Diabetes Metab; 2004 Sep; 30(4):341-6. PubMed ID: 15525877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
    Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy.
    Lange CAK; Stavrakas P; Luhmann UFO; de Silva DJ; Ali RR; Gregor ZJ; Bainbridge JWB
    Am J Ophthalmol; 2011 Sep; 152(3):406-412.e3. PubMed ID: 21723532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy.
    Takeuchi M; Sato T; Sakurai Y; Taguchi M; Harimoto K; Karasawa Y; Ito M
    PLoS One; 2017; 12(5):e0178230. PubMed ID: 28558009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated intravitreal interleukin-6 levels in patients with proliferative diabetic retinopathy.
    Mocan MC; Kadayifcilar S; Eldem B
    Can J Ophthalmol; 2006 Dec; 41(6):747-52. PubMed ID: 17224958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.